Global Penicillin Drugs Market

Penicillin Drugs Comprehensive Study by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other), Bacteria (Streptococcus pneumonia, Listeria, Neisseria gonorrhoea, Clostridium, Peptococcus, Peptostreptococcus.), Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA, Others), Source (Natural, Biosynthesis, Semisynthesis) Players and Region - Global Market Outlook to 2026

Penicillin Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Penicillin Drugs?
Penicillin’s are a type of antibiotics derived from Penicillium moulds, especially P. chrysogenum and P. Rubens. The majority of penicillins in scientific use are chemically synthesised from naturally going on penicillin’s. Although quite a few herbal penicillins have been discovered, solely two purified compounds are presently in medical use: penicillin G (intravenous use) and penicillin V (oral use) (given through mouth). Penicillins had been amongst the first antibiotics to be nice towards a broad vary of staphylococcal and streptococcal infections. They belong to the category of antibiotics recognized as -lactams. [2] They are nevertheless broadly used these days for a variety of bacterial infections, even though many sorts of micro organism have developed resistance as a end result of their massive use. Adverse results diarrhoea that is both watery or bloody; Fever, chills, physique aches, and flu-like symptoms, Unusual bruising or bleeding, as properly as uncommon weakness; Urinating much less often or no longer at all; Severe rash, itching, or peeling of the skin; agitation, confusion, uncommon ideas or behaviour; or Seizure.

The market study is broken down and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Penicillin Drugs market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Merck & Co., Inc. (United States), Allergan plc (AbbVie) (United States), GlaxoSmithKline plc. (United Kingdom), Pfizer Inc. (United States), Melinta Therapeutics (United States), Basilea Pharmaceutica Ltd. (Switzerland), Tetraphase Pharmaceuticals (United States), Paratek Pharmaceuticals, Inc. (United States), Nabriva Therapeutics plc (Ireland) and Spero Therapeutics (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Penicillin Drugs market by Type, Application and Region.

On the basis of geography, the market of Penicillin Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Penicillin Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Bacteria, the sub-segment i.e. Streptococcus pneumonia will boost the Penicillin Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Class, the sub-segment i.e. Cephalosporin will boost the Penicillin Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Source, the sub-segment i.e. Natural will boost the Penicillin Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In 2021, Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, declared the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA), seeking approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible microorganisms. If approved, tebipenem HBr would be the only oral carbapenem antibiotic available for use in cUTI.


Market Trend
  • New and innovative product are developing

Market Drivers
  • High prevalence of infectious diseases, such as lower respiratory infections, pneumonia, and others

Opportunities
  • Growing healthcare expenditure
  • Promoting the R&D activities of innovative therapies to control infectious diseases

Restraints
  • Increasing resistance to Anti-microbials

Challenges
  • Fluctuations in drugs supply and demand share due to enforcement of stringent lockdown measures


Key Target Audience
Penicillin Drugs Manufacturers, Penicillin Drugs Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other

By Bacteria
  • Streptococcus pneumonia
  • Listeria
  • Neisseria gonorrhoea
  • Clostridium
  • Peptococcus
  • Peptostreptococcus.

By Class
  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolide
  • Carbapenem
  • Aminoglycoside
  • Sulfonamide
  • 7-ACA
  • Others

By Source
  • Natural
  • Biosynthesis
  • Semisynthesis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High prevalence of infectious diseases, such as lower respiratory infections, pneumonia, and others
    • 3.3. Market Challenges
      • 3.3.1. Fluctuations in drugs supply and demand share due to enforcement of stringent lockdown measures
    • 3.4. Market Trends
      • 3.4.1. New and innovative product are developing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Penicillin Drugs, by Distribution Channel, Bacteria, Class, Source and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Penicillin Drugs (Value)
      • 5.2.1. Global Penicillin Drugs by: Distribution Channel (Value)
        • 5.2.1.1. Hospital Pharmacies
        • 5.2.1.2. Retail Pharmacies
        • 5.2.1.3. Online Pharmacies
        • 5.2.1.4. Other
      • 5.2.2. Global Penicillin Drugs by: Bacteria (Value)
        • 5.2.2.1. Streptococcus pneumonia
        • 5.2.2.2. Listeria
        • 5.2.2.3. Neisseria gonorrhoea
        • 5.2.2.4. Clostridium
        • 5.2.2.5. Peptococcus
        • 5.2.2.6. Peptostreptococcus.
      • 5.2.3. Global Penicillin Drugs by: Class (Value)
        • 5.2.3.1. Cephalosporin
        • 5.2.3.2. Penicillin
        • 5.2.3.3. Fluoroquinolone
        • 5.2.3.4. Macrolide
        • 5.2.3.5. Carbapenem
        • 5.2.3.6. Aminoglycoside
        • 5.2.3.7. Sulfonamide
        • 5.2.3.8. 7-ACA
        • 5.2.3.9. Others
      • 5.2.4. Global Penicillin Drugs by: Source (Value)
        • 5.2.4.1. Natural
        • 5.2.4.2. Biosynthesis
        • 5.2.4.3. Semisynthesis
      • 5.2.5. Global Penicillin Drugs Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Penicillin Drugs (Volume)
      • 5.3.1. Global Penicillin Drugs by: Distribution Channel (Volume)
        • 5.3.1.1. Hospital Pharmacies
        • 5.3.1.2. Retail Pharmacies
        • 5.3.1.3. Online Pharmacies
        • 5.3.1.4. Other
      • 5.3.2. Global Penicillin Drugs by: Bacteria (Volume)
        • 5.3.2.1. Streptococcus pneumonia
        • 5.3.2.2. Listeria
        • 5.3.2.3. Neisseria gonorrhoea
        • 5.3.2.4. Clostridium
        • 5.3.2.5. Peptococcus
        • 5.3.2.6. Peptostreptococcus.
      • 5.3.3. Global Penicillin Drugs by: Class (Volume)
        • 5.3.3.1. Cephalosporin
        • 5.3.3.2. Penicillin
        • 5.3.3.3. Fluoroquinolone
        • 5.3.3.4. Macrolide
        • 5.3.3.5. Carbapenem
        • 5.3.3.6. Aminoglycoside
        • 5.3.3.7. Sulfonamide
        • 5.3.3.8. 7-ACA
        • 5.3.3.9. Others
      • 5.3.4. Global Penicillin Drugs by: Source (Volume)
        • 5.3.4.1. Natural
        • 5.3.4.2. Biosynthesis
        • 5.3.4.3. Semisynthesis
      • 5.3.5. Global Penicillin Drugs Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Penicillin Drugs (Price)
  • 6. Penicillin Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co., Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Allergan plc (AbbVie) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline plc. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Melinta Therapeutics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Basilea Pharmaceutica Ltd. (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Tetraphase Pharmaceuticals (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Paratek Pharmaceuticals, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nabriva Therapeutics plc (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Spero Therapeutics (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Penicillin Drugs Sale, by Distribution Channel, Bacteria, Class, Source and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Penicillin Drugs (Value)
      • 7.2.1. Global Penicillin Drugs by: Distribution Channel (Value)
        • 7.2.1.1. Hospital Pharmacies
        • 7.2.1.2. Retail Pharmacies
        • 7.2.1.3. Online Pharmacies
        • 7.2.1.4. Other
      • 7.2.2. Global Penicillin Drugs by: Bacteria (Value)
        • 7.2.2.1. Streptococcus pneumonia
        • 7.2.2.2. Listeria
        • 7.2.2.3. Neisseria gonorrhoea
        • 7.2.2.4. Clostridium
        • 7.2.2.5. Peptococcus
        • 7.2.2.6. Peptostreptococcus.
      • 7.2.3. Global Penicillin Drugs by: Class (Value)
        • 7.2.3.1. Cephalosporin
        • 7.2.3.2. Penicillin
        • 7.2.3.3. Fluoroquinolone
        • 7.2.3.4. Macrolide
        • 7.2.3.5. Carbapenem
        • 7.2.3.6. Aminoglycoside
        • 7.2.3.7. Sulfonamide
        • 7.2.3.8. 7-ACA
        • 7.2.3.9. Others
      • 7.2.4. Global Penicillin Drugs by: Source (Value)
        • 7.2.4.1. Natural
        • 7.2.4.2. Biosynthesis
        • 7.2.4.3. Semisynthesis
      • 7.2.5. Global Penicillin Drugs Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Penicillin Drugs (Volume)
      • 7.3.1. Global Penicillin Drugs by: Distribution Channel (Volume)
        • 7.3.1.1. Hospital Pharmacies
        • 7.3.1.2. Retail Pharmacies
        • 7.3.1.3. Online Pharmacies
        • 7.3.1.4. Other
      • 7.3.2. Global Penicillin Drugs by: Bacteria (Volume)
        • 7.3.2.1. Streptococcus pneumonia
        • 7.3.2.2. Listeria
        • 7.3.2.3. Neisseria gonorrhoea
        • 7.3.2.4. Clostridium
        • 7.3.2.5. Peptococcus
        • 7.3.2.6. Peptostreptococcus.
      • 7.3.3. Global Penicillin Drugs by: Class (Volume)
        • 7.3.3.1. Cephalosporin
        • 7.3.3.2. Penicillin
        • 7.3.3.3. Fluoroquinolone
        • 7.3.3.4. Macrolide
        • 7.3.3.5. Carbapenem
        • 7.3.3.6. Aminoglycoside
        • 7.3.3.7. Sulfonamide
        • 7.3.3.8. 7-ACA
        • 7.3.3.9. Others
      • 7.3.4. Global Penicillin Drugs by: Source (Volume)
        • 7.3.4.1. Natural
        • 7.3.4.2. Biosynthesis
        • 7.3.4.3. Semisynthesis
      • 7.3.5. Global Penicillin Drugs Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Penicillin Drugs (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Penicillin Drugs: by Distribution Channel(USD Million)
  • Table 2. Penicillin Drugs Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 3. Penicillin Drugs Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 4. Penicillin Drugs Online Pharmacies , by Region USD Million (2015-2020)
  • Table 5. Penicillin Drugs Other , by Region USD Million (2015-2020)
  • Table 6. Penicillin Drugs: by Bacteria(USD Million)
  • Table 7. Penicillin Drugs Streptococcus pneumonia , by Region USD Million (2015-2020)
  • Table 8. Penicillin Drugs Listeria , by Region USD Million (2015-2020)
  • Table 9. Penicillin Drugs Neisseria gonorrhoea , by Region USD Million (2015-2020)
  • Table 10. Penicillin Drugs Clostridium , by Region USD Million (2015-2020)
  • Table 11. Penicillin Drugs Peptococcus , by Region USD Million (2015-2020)
  • Table 12. Penicillin Drugs Peptostreptococcus. , by Region USD Million (2015-2020)
  • Table 13. Penicillin Drugs: by Class(USD Million)
  • Table 14. Penicillin Drugs Cephalosporin , by Region USD Million (2015-2020)
  • Table 15. Penicillin Drugs Penicillin , by Region USD Million (2015-2020)
  • Table 16. Penicillin Drugs Fluoroquinolone , by Region USD Million (2015-2020)
  • Table 17. Penicillin Drugs Macrolide , by Region USD Million (2015-2020)
  • Table 18. Penicillin Drugs Carbapenem , by Region USD Million (2015-2020)
  • Table 19. Penicillin Drugs Aminoglycoside , by Region USD Million (2015-2020)
  • Table 20. Penicillin Drugs Sulfonamide , by Region USD Million (2015-2020)
  • Table 21. Penicillin Drugs 7-ACA , by Region USD Million (2015-2020)
  • Table 22. Penicillin Drugs Others , by Region USD Million (2015-2020)
  • Table 23. Penicillin Drugs: by Source(USD Million)
  • Table 24. Penicillin Drugs Natural , by Region USD Million (2015-2020)
  • Table 25. Penicillin Drugs Biosynthesis , by Region USD Million (2015-2020)
  • Table 26. Penicillin Drugs Semisynthesis , by Region USD Million (2015-2020)
  • Table 27. South America Penicillin Drugs, by Country USD Million (2015-2020)
  • Table 28. South America Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 29. South America Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 30. South America Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 31. South America Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 32. Brazil Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 33. Brazil Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 34. Brazil Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 35. Brazil Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 36. Argentina Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 37. Argentina Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 38. Argentina Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 39. Argentina Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 40. Rest of South America Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 41. Rest of South America Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 42. Rest of South America Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 43. Rest of South America Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 44. Asia Pacific Penicillin Drugs, by Country USD Million (2015-2020)
  • Table 45. Asia Pacific Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 46. Asia Pacific Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 47. Asia Pacific Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 48. Asia Pacific Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 49. China Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 50. China Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 51. China Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 52. China Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 53. Japan Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 54. Japan Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 55. Japan Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 56. Japan Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 57. India Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 58. India Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 59. India Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 60. India Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 61. South Korea Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 62. South Korea Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 63. South Korea Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 64. South Korea Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 65. Taiwan Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 66. Taiwan Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 67. Taiwan Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 68. Taiwan Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 69. Australia Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 70. Australia Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 71. Australia Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 72. Australia Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 77. Europe Penicillin Drugs, by Country USD Million (2015-2020)
  • Table 78. Europe Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 79. Europe Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 80. Europe Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 81. Europe Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 82. Germany Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 83. Germany Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 84. Germany Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 85. Germany Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 86. France Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 87. France Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 88. France Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 89. France Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 90. Italy Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 91. Italy Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 92. Italy Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 93. Italy Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 94. United Kingdom Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 95. United Kingdom Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 96. United Kingdom Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 97. United Kingdom Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 98. Netherlands Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 99. Netherlands Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 100. Netherlands Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 101. Netherlands Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 102. Rest of Europe Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 103. Rest of Europe Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 104. Rest of Europe Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 105. Rest of Europe Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 106. MEA Penicillin Drugs, by Country USD Million (2015-2020)
  • Table 107. MEA Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 108. MEA Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 109. MEA Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 110. MEA Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 111. Middle East Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 112. Middle East Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 113. Middle East Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 114. Middle East Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 115. Africa Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 116. Africa Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 117. Africa Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 118. Africa Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 119. North America Penicillin Drugs, by Country USD Million (2015-2020)
  • Table 120. North America Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 121. North America Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 122. North America Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 123. North America Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 124. United States Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 125. United States Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 126. United States Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 127. United States Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 128. Canada Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 129. Canada Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 130. Canada Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 131. Canada Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 132. Mexico Penicillin Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 133. Mexico Penicillin Drugs, by Bacteria USD Million (2015-2020)
  • Table 134. Mexico Penicillin Drugs, by Class USD Million (2015-2020)
  • Table 135. Mexico Penicillin Drugs, by Source USD Million (2015-2020)
  • Table 136. Penicillin Drugs Sales: by Distribution Channel(K Units)
  • Table 137. Penicillin Drugs Sales Hospital Pharmacies , by Region K Units (2015-2020)
  • Table 138. Penicillin Drugs Sales Retail Pharmacies , by Region K Units (2015-2020)
  • Table 139. Penicillin Drugs Sales Online Pharmacies , by Region K Units (2015-2020)
  • Table 140. Penicillin Drugs Sales Other , by Region K Units (2015-2020)
  • Table 141. Penicillin Drugs Sales: by Bacteria(K Units)
  • Table 142. Penicillin Drugs Sales Streptococcus pneumonia , by Region K Units (2015-2020)
  • Table 143. Penicillin Drugs Sales Listeria , by Region K Units (2015-2020)
  • Table 144. Penicillin Drugs Sales Neisseria gonorrhoea , by Region K Units (2015-2020)
  • Table 145. Penicillin Drugs Sales Clostridium , by Region K Units (2015-2020)
  • Table 146. Penicillin Drugs Sales Peptococcus , by Region K Units (2015-2020)
  • Table 147. Penicillin Drugs Sales Peptostreptococcus. , by Region K Units (2015-2020)
  • Table 148. Penicillin Drugs Sales: by Class(K Units)
  • Table 149. Penicillin Drugs Sales Cephalosporin , by Region K Units (2015-2020)
  • Table 150. Penicillin Drugs Sales Penicillin , by Region K Units (2015-2020)
  • Table 151. Penicillin Drugs Sales Fluoroquinolone , by Region K Units (2015-2020)
  • Table 152. Penicillin Drugs Sales Macrolide , by Region K Units (2015-2020)
  • Table 153. Penicillin Drugs Sales Carbapenem , by Region K Units (2015-2020)
  • Table 154. Penicillin Drugs Sales Aminoglycoside , by Region K Units (2015-2020)
  • Table 155. Penicillin Drugs Sales Sulfonamide , by Region K Units (2015-2020)
  • Table 156. Penicillin Drugs Sales 7-ACA , by Region K Units (2015-2020)
  • Table 157. Penicillin Drugs Sales Others , by Region K Units (2015-2020)
  • Table 158. Penicillin Drugs Sales: by Source(K Units)
  • Table 159. Penicillin Drugs Sales Natural , by Region K Units (2015-2020)
  • Table 160. Penicillin Drugs Sales Biosynthesis , by Region K Units (2015-2020)
  • Table 161. Penicillin Drugs Sales Semisynthesis , by Region K Units (2015-2020)
  • Table 162. South America Penicillin Drugs Sales, by Country K Units (2015-2020)
  • Table 163. South America Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 164. South America Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 165. South America Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 166. South America Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 167. Brazil Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 168. Brazil Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 169. Brazil Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 170. Brazil Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 171. Argentina Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 172. Argentina Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 173. Argentina Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 174. Argentina Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 175. Rest of South America Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 176. Rest of South America Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 177. Rest of South America Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 178. Rest of South America Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 179. Asia Pacific Penicillin Drugs Sales, by Country K Units (2015-2020)
  • Table 180. Asia Pacific Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 181. Asia Pacific Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 182. Asia Pacific Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 183. Asia Pacific Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 184. China Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 185. China Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 186. China Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 187. China Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 188. Japan Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 189. Japan Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 190. Japan Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 191. Japan Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 192. India Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 193. India Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 194. India Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 195. India Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 196. South Korea Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 197. South Korea Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 198. South Korea Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 199. South Korea Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 200. Taiwan Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 201. Taiwan Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 202. Taiwan Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 203. Taiwan Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 204. Australia Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 205. Australia Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 206. Australia Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 207. Australia Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 208. Rest of Asia-Pacific Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 209. Rest of Asia-Pacific Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 210. Rest of Asia-Pacific Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 211. Rest of Asia-Pacific Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 212. Europe Penicillin Drugs Sales, by Country K Units (2015-2020)
  • Table 213. Europe Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 214. Europe Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 215. Europe Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 216. Europe Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 217. Germany Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 218. Germany Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 219. Germany Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 220. Germany Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 221. France Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 222. France Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 223. France Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 224. France Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 225. Italy Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 226. Italy Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 227. Italy Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 228. Italy Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 229. United Kingdom Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 230. United Kingdom Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 231. United Kingdom Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 232. United Kingdom Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 233. Netherlands Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 234. Netherlands Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 235. Netherlands Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 236. Netherlands Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 237. Rest of Europe Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 238. Rest of Europe Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 239. Rest of Europe Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 240. Rest of Europe Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 241. MEA Penicillin Drugs Sales, by Country K Units (2015-2020)
  • Table 242. MEA Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 243. MEA Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 244. MEA Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 245. MEA Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 246. Middle East Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 247. Middle East Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 248. Middle East Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 249. Middle East Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 250. Africa Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 251. Africa Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 252. Africa Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 253. Africa Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 254. North America Penicillin Drugs Sales, by Country K Units (2015-2020)
  • Table 255. North America Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 256. North America Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 257. North America Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 258. North America Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 259. United States Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 260. United States Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 261. United States Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 262. United States Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 263. Canada Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 264. Canada Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 265. Canada Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 266. Canada Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 267. Mexico Penicillin Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 268. Mexico Penicillin Drugs Sales, by Bacteria K Units (2015-2020)
  • Table 269. Mexico Penicillin Drugs Sales, by Class K Units (2015-2020)
  • Table 270. Mexico Penicillin Drugs Sales, by Source K Units (2015-2020)
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Company Basic Information, Sales Area and Its Competitors
  • Table 274. Company Basic Information, Sales Area and Its Competitors
  • Table 275. Company Basic Information, Sales Area and Its Competitors
  • Table 276. Company Basic Information, Sales Area and Its Competitors
  • Table 277. Company Basic Information, Sales Area and Its Competitors
  • Table 278. Company Basic Information, Sales Area and Its Competitors
  • Table 279. Company Basic Information, Sales Area and Its Competitors
  • Table 280. Company Basic Information, Sales Area and Its Competitors
  • Table 281. Penicillin Drugs: by Distribution Channel(USD Million)
  • Table 282. Penicillin Drugs Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 283. Penicillin Drugs Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 284. Penicillin Drugs Online Pharmacies , by Region USD Million (2021-2026)
  • Table 285. Penicillin Drugs Other , by Region USD Million (2021-2026)
  • Table 286. Penicillin Drugs: by Bacteria(USD Million)
  • Table 287. Penicillin Drugs Streptococcus pneumonia , by Region USD Million (2021-2026)
  • Table 288. Penicillin Drugs Listeria , by Region USD Million (2021-2026)
  • Table 289. Penicillin Drugs Neisseria gonorrhoea , by Region USD Million (2021-2026)
  • Table 290. Penicillin Drugs Clostridium , by Region USD Million (2021-2026)
  • Table 291. Penicillin Drugs Peptococcus , by Region USD Million (2021-2026)
  • Table 292. Penicillin Drugs Peptostreptococcus. , by Region USD Million (2021-2026)
  • Table 293. Penicillin Drugs: by Class(USD Million)
  • Table 294. Penicillin Drugs Cephalosporin , by Region USD Million (2021-2026)
  • Table 295. Penicillin Drugs Penicillin , by Region USD Million (2021-2026)
  • Table 296. Penicillin Drugs Fluoroquinolone , by Region USD Million (2021-2026)
  • Table 297. Penicillin Drugs Macrolide , by Region USD Million (2021-2026)
  • Table 298. Penicillin Drugs Carbapenem , by Region USD Million (2021-2026)
  • Table 299. Penicillin Drugs Aminoglycoside , by Region USD Million (2021-2026)
  • Table 300. Penicillin Drugs Sulfonamide , by Region USD Million (2021-2026)
  • Table 301. Penicillin Drugs 7-ACA , by Region USD Million (2021-2026)
  • Table 302. Penicillin Drugs Others , by Region USD Million (2021-2026)
  • Table 303. Penicillin Drugs: by Source(USD Million)
  • Table 304. Penicillin Drugs Natural , by Region USD Million (2021-2026)
  • Table 305. Penicillin Drugs Biosynthesis , by Region USD Million (2021-2026)
  • Table 306. Penicillin Drugs Semisynthesis , by Region USD Million (2021-2026)
  • Table 307. South America Penicillin Drugs, by Country USD Million (2021-2026)
  • Table 308. South America Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 309. South America Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 310. South America Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 311. South America Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 312. Brazil Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 313. Brazil Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 314. Brazil Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 315. Brazil Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 316. Argentina Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 317. Argentina Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 318. Argentina Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 319. Argentina Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 320. Rest of South America Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 321. Rest of South America Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 322. Rest of South America Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 323. Rest of South America Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 324. Asia Pacific Penicillin Drugs, by Country USD Million (2021-2026)
  • Table 325. Asia Pacific Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 326. Asia Pacific Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 327. Asia Pacific Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 328. Asia Pacific Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 329. China Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 330. China Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 331. China Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 332. China Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 333. Japan Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 334. Japan Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 335. Japan Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 336. Japan Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 337. India Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 338. India Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 339. India Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 340. India Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 341. South Korea Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 342. South Korea Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 343. South Korea Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 344. South Korea Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 345. Taiwan Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 346. Taiwan Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 347. Taiwan Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 348. Taiwan Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 349. Australia Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 350. Australia Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 351. Australia Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 352. Australia Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 353. Rest of Asia-Pacific Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 354. Rest of Asia-Pacific Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 355. Rest of Asia-Pacific Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 356. Rest of Asia-Pacific Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 357. Europe Penicillin Drugs, by Country USD Million (2021-2026)
  • Table 358. Europe Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 359. Europe Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 360. Europe Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 361. Europe Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 362. Germany Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 363. Germany Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 364. Germany Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 365. Germany Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 366. France Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 367. France Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 368. France Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 369. France Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 370. Italy Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 371. Italy Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 372. Italy Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 373. Italy Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 374. United Kingdom Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 375. United Kingdom Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 376. United Kingdom Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 377. United Kingdom Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 378. Netherlands Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 379. Netherlands Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 380. Netherlands Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 381. Netherlands Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 382. Rest of Europe Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 383. Rest of Europe Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 384. Rest of Europe Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 385. Rest of Europe Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 386. MEA Penicillin Drugs, by Country USD Million (2021-2026)
  • Table 387. MEA Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 388. MEA Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 389. MEA Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 390. MEA Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 391. Middle East Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 392. Middle East Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 393. Middle East Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 394. Middle East Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 395. Africa Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 396. Africa Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 397. Africa Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 398. Africa Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 399. North America Penicillin Drugs, by Country USD Million (2021-2026)
  • Table 400. North America Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 401. North America Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 402. North America Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 403. North America Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 404. United States Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 405. United States Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 406. United States Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 407. United States Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 408. Canada Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 409. Canada Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 410. Canada Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 411. Canada Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 412. Mexico Penicillin Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 413. Mexico Penicillin Drugs, by Bacteria USD Million (2021-2026)
  • Table 414. Mexico Penicillin Drugs, by Class USD Million (2021-2026)
  • Table 415. Mexico Penicillin Drugs, by Source USD Million (2021-2026)
  • Table 416. Penicillin Drugs Sales: by Distribution Channel(K Units)
  • Table 417. Penicillin Drugs Sales Hospital Pharmacies , by Region K Units (2021-2026)
  • Table 418. Penicillin Drugs Sales Retail Pharmacies , by Region K Units (2021-2026)
  • Table 419. Penicillin Drugs Sales Online Pharmacies , by Region K Units (2021-2026)
  • Table 420. Penicillin Drugs Sales Other , by Region K Units (2021-2026)
  • Table 421. Penicillin Drugs Sales: by Bacteria(K Units)
  • Table 422. Penicillin Drugs Sales Streptococcus pneumonia , by Region K Units (2021-2026)
  • Table 423. Penicillin Drugs Sales Listeria , by Region K Units (2021-2026)
  • Table 424. Penicillin Drugs Sales Neisseria gonorrhoea , by Region K Units (2021-2026)
  • Table 425. Penicillin Drugs Sales Clostridium , by Region K Units (2021-2026)
  • Table 426. Penicillin Drugs Sales Peptococcus , by Region K Units (2021-2026)
  • Table 427. Penicillin Drugs Sales Peptostreptococcus. , by Region K Units (2021-2026)
  • Table 428. Penicillin Drugs Sales: by Class(K Units)
  • Table 429. Penicillin Drugs Sales Cephalosporin , by Region K Units (2021-2026)
  • Table 430. Penicillin Drugs Sales Penicillin , by Region K Units (2021-2026)
  • Table 431. Penicillin Drugs Sales Fluoroquinolone , by Region K Units (2021-2026)
  • Table 432. Penicillin Drugs Sales Macrolide , by Region K Units (2021-2026)
  • Table 433. Penicillin Drugs Sales Carbapenem , by Region K Units (2021-2026)
  • Table 434. Penicillin Drugs Sales Aminoglycoside , by Region K Units (2021-2026)
  • Table 435. Penicillin Drugs Sales Sulfonamide , by Region K Units (2021-2026)
  • Table 436. Penicillin Drugs Sales 7-ACA , by Region K Units (2021-2026)
  • Table 437. Penicillin Drugs Sales Others , by Region K Units (2021-2026)
  • Table 438. Penicillin Drugs Sales: by Source(K Units)
  • Table 439. Penicillin Drugs Sales Natural , by Region K Units (2021-2026)
  • Table 440. Penicillin Drugs Sales Biosynthesis , by Region K Units (2021-2026)
  • Table 441. Penicillin Drugs Sales Semisynthesis , by Region K Units (2021-2026)
  • Table 442. South America Penicillin Drugs Sales, by Country K Units (2021-2026)
  • Table 443. South America Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 444. South America Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 445. South America Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 446. South America Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 447. Brazil Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 448. Brazil Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 449. Brazil Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 450. Brazil Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 451. Argentina Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 452. Argentina Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 453. Argentina Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 454. Argentina Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 455. Rest of South America Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 456. Rest of South America Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 457. Rest of South America Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 458. Rest of South America Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 459. Asia Pacific Penicillin Drugs Sales, by Country K Units (2021-2026)
  • Table 460. Asia Pacific Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 461. Asia Pacific Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 462. Asia Pacific Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 463. Asia Pacific Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 464. China Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 465. China Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 466. China Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 467. China Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 468. Japan Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 469. Japan Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 470. Japan Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 471. Japan Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 472. India Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 473. India Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 474. India Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 475. India Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 476. South Korea Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 477. South Korea Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 478. South Korea Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 479. South Korea Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 480. Taiwan Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 481. Taiwan Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 482. Taiwan Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 483. Taiwan Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 484. Australia Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 485. Australia Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 486. Australia Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 487. Australia Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 488. Rest of Asia-Pacific Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 489. Rest of Asia-Pacific Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 490. Rest of Asia-Pacific Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 491. Rest of Asia-Pacific Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 492. Europe Penicillin Drugs Sales, by Country K Units (2021-2026)
  • Table 493. Europe Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 494. Europe Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 495. Europe Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 496. Europe Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 497. Germany Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 498. Germany Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 499. Germany Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 500. Germany Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 501. France Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 502. France Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 503. France Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 504. France Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 505. Italy Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 506. Italy Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 507. Italy Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 508. Italy Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 509. United Kingdom Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 510. United Kingdom Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 511. United Kingdom Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 512. United Kingdom Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 513. Netherlands Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 514. Netherlands Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 515. Netherlands Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 516. Netherlands Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 517. Rest of Europe Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 518. Rest of Europe Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 519. Rest of Europe Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 520. Rest of Europe Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 521. MEA Penicillin Drugs Sales, by Country K Units (2021-2026)
  • Table 522. MEA Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 523. MEA Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 524. MEA Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 525. MEA Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 526. Middle East Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 527. Middle East Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 528. Middle East Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 529. Middle East Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 530. Africa Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 531. Africa Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 532. Africa Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 533. Africa Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 534. North America Penicillin Drugs Sales, by Country K Units (2021-2026)
  • Table 535. North America Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 536. North America Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 537. North America Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 538. North America Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 539. United States Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 540. United States Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 541. United States Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 542. United States Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 543. Canada Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 544. Canada Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 545. Canada Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 546. Canada Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 547. Mexico Penicillin Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 548. Mexico Penicillin Drugs Sales, by Bacteria K Units (2021-2026)
  • Table 549. Mexico Penicillin Drugs Sales, by Class K Units (2021-2026)
  • Table 550. Mexico Penicillin Drugs Sales, by Source K Units (2021-2026)
  • Table 551. Research Programs/Design for This Report
  • Table 552. Key Data Information from Secondary Sources
  • Table 553. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Penicillin Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 5. Global Penicillin Drugs: by Bacteria USD Million (2015-2020)
  • Figure 6. Global Penicillin Drugs: by Class USD Million (2015-2020)
  • Figure 7. Global Penicillin Drugs: by Source USD Million (2015-2020)
  • Figure 8. South America Penicillin Drugs Share (%), by Country
  • Figure 9. Asia Pacific Penicillin Drugs Share (%), by Country
  • Figure 10. Europe Penicillin Drugs Share (%), by Country
  • Figure 11. MEA Penicillin Drugs Share (%), by Country
  • Figure 12. North America Penicillin Drugs Share (%), by Country
  • Figure 13. Global Penicillin Drugs: by Distribution Channel K Units (2015-2020)
  • Figure 14. Global Penicillin Drugs: by Bacteria K Units (2015-2020)
  • Figure 15. Global Penicillin Drugs: by Class K Units (2015-2020)
  • Figure 16. Global Penicillin Drugs: by Source K Units (2015-2020)
  • Figure 17. South America Penicillin Drugs Share (%), by Country
  • Figure 18. Asia Pacific Penicillin Drugs Share (%), by Country
  • Figure 19. Europe Penicillin Drugs Share (%), by Country
  • Figure 20. MEA Penicillin Drugs Share (%), by Country
  • Figure 21. North America Penicillin Drugs Share (%), by Country
  • Figure 22. Global Penicillin Drugs share by Players 2020 (%)
  • Figure 23. Global Penicillin Drugs share by Players (Top 3) 2020(%)
  • Figure 24. Global Penicillin Drugs share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Merck & Co., Inc. (United States) Revenue: by Geography 2020
  • Figure 28. Allergan plc (AbbVie) (United States) Revenue, Net Income and Gross profit
  • Figure 29. Allergan plc (AbbVie) (United States) Revenue: by Geography 2020
  • Figure 30. GlaxoSmithKline plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. GlaxoSmithKline plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 32. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Melinta Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 35. Melinta Therapeutics (United States) Revenue: by Geography 2020
  • Figure 36. Basilea Pharmaceutica Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Basilea Pharmaceutica Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 38. Tetraphase Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 39. Tetraphase Pharmaceuticals (United States) Revenue: by Geography 2020
  • Figure 40. Paratek Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Paratek Pharmaceuticals, Inc. (United States) Revenue: by Geography 2020
  • Figure 42. Nabriva Therapeutics plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 43. Nabriva Therapeutics plc (Ireland) Revenue: by Geography 2020
  • Figure 44. Spero Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 45. Spero Therapeutics (United States) Revenue: by Geography 2020
  • Figure 46. Global Penicillin Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 47. Global Penicillin Drugs: by Bacteria USD Million (2021-2026)
  • Figure 48. Global Penicillin Drugs: by Class USD Million (2021-2026)
  • Figure 49. Global Penicillin Drugs: by Source USD Million (2021-2026)
  • Figure 50. South America Penicillin Drugs Share (%), by Country
  • Figure 51. Asia Pacific Penicillin Drugs Share (%), by Country
  • Figure 52. Europe Penicillin Drugs Share (%), by Country
  • Figure 53. MEA Penicillin Drugs Share (%), by Country
  • Figure 54. North America Penicillin Drugs Share (%), by Country
  • Figure 55. Global Penicillin Drugs: by Distribution Channel K Units (2021-2026)
  • Figure 56. Global Penicillin Drugs: by Bacteria K Units (2021-2026)
  • Figure 57. Global Penicillin Drugs: by Class K Units (2021-2026)
  • Figure 58. Global Penicillin Drugs: by Source K Units (2021-2026)
  • Figure 59. South America Penicillin Drugs Share (%), by Country
  • Figure 60. Asia Pacific Penicillin Drugs Share (%), by Country
  • Figure 61. Europe Penicillin Drugs Share (%), by Country
  • Figure 62. MEA Penicillin Drugs Share (%), by Country
  • Figure 63. North America Penicillin Drugs Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck & Co., Inc. (United States)
  • Allergan plc (AbbVie) (United States)
  • GlaxoSmithKline plc. (United Kingdom)
  • Pfizer Inc. (United States)
  • Melinta Therapeutics (United States)
  • Basilea Pharmaceutica Ltd. (Switzerland)
  • Tetraphase Pharmaceuticals (United States)
  • Paratek Pharmaceuticals, Inc. (United States)
  • Nabriva Therapeutics plc (Ireland)
  • Spero Therapeutics (United States)
Select User Access Type

Key Highlights of Report


Jan 2022 211 Pages 87 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Penicillin Drugs Market Quantitative research analysis
Global Penicillin Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Merck & Co., Inc. (United States), Allergan plc (AbbVie) (United States), GlaxoSmithKline plc. (United Kingdom), Pfizer Inc. (United States), Melinta Therapeutics (United States), Basilea Pharmaceutica Ltd. (Switzerland), Tetraphase Pharmaceuticals (United States), Paratek Pharmaceuticals, Inc. (United States), Nabriva Therapeutics plc (Ireland) and Spero Therapeutics (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Penicillin Drugs Market to reach USD Million by 2026.

Know More About Global Penicillin Drugs Market Report?

Have a Query? Click Here

Other Related Reports

At-Home Health Testing Comprehensive Study by Usage (Disposable, Reusable), Distribution Channel (Online {Brand Website, E-Commerce Website}, Offline {Retail Pharmacies, Drug Stores, Supermarket/Hype...
$ 3750
Clenbuterol Comprehensive Study by Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD)), Forms (Tablet, Inhaler Form), Side Effect (Anxiety, Shaking, Headaches, Abnormal Sweating), Dis...
$ 3800
Clozapine Tablet Comprehensive Study by Type (100 mg, 50 mg, 25 mg), End-users (Hospitals, Clinics, Ambulatory Surgical Centers, Pharmacies, Others), Age Group (Pediatric, Adult, Geriatric), Side Eff...
$ 3800
Adjuvant Therapy Comprehensive Study by Type (Radiation Therapy, Chemotherapy, Immunotherapy, Hormone Therapy, Targeted Therapy), Application (Hospital, Clinics, Ambulatory Surgical Centers), Side Ef...
$ 3800
Pharmaceutical Contract Research and Manufacturing Comprehensive Study by Services (Synthetic Route Design & Scouting Services, High-end Chemical Process Development, Advanced Drug Delivery Formulati...
$ 3750
Nucleic Vaccine Comprehensive Study by Application (Hospital, Clinic, Others), Disease (AIDS, Hepatitis B and C, Influenza, Warts) Players and Region - Global Market Outlook to 2026
$ 3500